170 related articles for article (PubMed ID: 26253621)
1. Concentrations of MDPV in rat striatum correlate with the psychostimulant effect.
Novellas J; López-Arnau R; Carbó ML; Pubill D; Camarasa J; Escubedo E
J Psychopharmacol; 2015 Nov; 29(11):1209-18. PubMed ID: 26253621
[TBL] [Abstract][Full Text] [Related]
2. Effects of MDPV on dopamine transporter regulation in male rats. Comparison with cocaine.
Lopez-Arnau R; Duart-Castells L; Aster B; Camarasa J; Escubedo E; Pubill D
Psychopharmacology (Berl); 2019 Mar; 236(3):925-938. PubMed ID: 30284596
[TBL] [Abstract][Full Text] [Related]
3. Repeated administration of synthetic cathinone 3,4-methylenedioxypyrovalerone persistently increases impulsive choice in rats.
Hyatt WS; Berquist MD; Chitre NM; Russell LN; Rice KC; Murnane KS; Fantegrossi WE
Behav Pharmacol; 2019 Oct; 30(7):555-565. PubMed ID: 31211703
[TBL] [Abstract][Full Text] [Related]
4. The effects of acute and repeated methylenedioxypyrovalerone (MDPV) administration on striatal transcriptome networks in male long evans rats.
Martyniuk CJ; Pompilus M; Schmidt J; Duncan A; Febo M
Neurosci Lett; 2019 Nov; 712():134499. PubMed ID: 31536752
[TBL] [Abstract][Full Text] [Related]
5. Changes in CREB and deltaFosB are associated with the behavioural sensitization induced by methylenedioxypyrovalerone.
Buenrostro-Jáuregui M; Ciudad-Roberts A; Moreno J; Muñoz-Villegas P; López-Arnau R; Pubill D; Escubedo E; Camarasa J
J Psychopharmacol; 2016 Jul; 30(7):707-12. PubMed ID: 27147595
[TBL] [Abstract][Full Text] [Related]
6. 3,4-Methylenedioxypyrovalerone: Neuropharmacological Impact of a Designer Stimulant of Abuse on Monoamine Transporters.
Magee CP; German CL; Siripathane YH; Curtis PS; Anderson DJ; Wilkins DG; Hanson GR; Fleckenstein AE
J Pharmacol Exp Ther; 2020 Aug; 374(2):273-282. PubMed ID: 32385092
[TBL] [Abstract][Full Text] [Related]
7. Linear pharmacokinetics of 3,4-methylenedioxypyrovalerone (MDPV) and its metabolites in the rat: relationship to pharmacodynamic effects.
Anizan S; Concheiro M; Lehner KR; Bukhari MO; Suzuki M; Rice KC; Baumann MH; Huestis MA
Addict Biol; 2016 Mar; 21(2):339-47. PubMed ID: 25475011
[TBL] [Abstract][Full Text] [Related]
8. Active vaccination attenuates the psychostimulant effects of α-PVP and MDPV in rats.
Nguyen JD; Bremer PT; Ducime A; Creehan KM; Kisby BR; Taffe MA; Janda KD
Neuropharmacology; 2017 Apr; 116():1-8. PubMed ID: 27956054
[TBL] [Abstract][Full Text] [Related]
9. Powerful cocaine-like actions of 3,4-methylenedioxypyrovalerone (MDPV), a principal constituent of psychoactive 'bath salts' products.
Baumann MH; Partilla JS; Lehner KR; Thorndike EB; Hoffman AF; Holy M; Rothman RB; Goldberg SR; Lupica CR; Sitte HH; Brandt SD; Tella SR; Cozzi NV; Schindler CW
Neuropsychopharmacology; 2013 Mar; 38(4):552-62. PubMed ID: 23072836
[TBL] [Abstract][Full Text] [Related]
10. The combination of MDPV and ethanol results in decreased cathinone and increased alcohol levels. Study of such pharmacological interaction.
López-Arnau R; Buenrostro-Jáuregui M; Muñoz-Villegas P; Rodríguez-Morató J; Ciudad-Roberts A; Duart L; Camarasa J; De la Torre R; Pubill D; Escubedo E
Prog Neuropsychopharmacol Biol Psychiatry; 2017 Jun; 76():19-28. PubMed ID: 28219712
[TBL] [Abstract][Full Text] [Related]
11. Conditioned place preference following concurrent treatment with 3, 4-methylenedioxypyrovalerone (MDPV) and methamphetamine in male and female Sprague-Dawley rats.
Risca HI; Zuarth-Gonzalez JD; Baker LE
Pharmacol Biochem Behav; 2020 Nov; 198():173032. PubMed ID: 32888971
[TBL] [Abstract][Full Text] [Related]
12. Pharmacology of novel synthetic stimulants structurally related to the "bath salts" constituent 3,4-methylenedioxypyrovalerone (MDPV).
Marusich JA; Antonazzo KR; Wiley JL; Blough BE; Partilla JS; Baumann MH
Neuropharmacology; 2014 Dec; 87():206-13. PubMed ID: 24594476
[TBL] [Abstract][Full Text] [Related]
13. Exposure of adolescent mice to 3,4-methylenedioxypyrovalerone increases the psychostimulant, rewarding and reinforcing effects of cocaine in adulthood.
López-Arnau R; Luján MA; Duart-Castells L; Pubill D; Camarasa J; Valverde O; Escubedo E
Br J Pharmacol; 2017 May; 174(10):1161-1173. PubMed ID: 28262947
[TBL] [Abstract][Full Text] [Related]
14. Dopaminergic Effects of Major Bath Salt Constituents 3,4-Methylenedioxypyrovalerone (MDPV), Mephedrone, and Methylone Are Enhanced Following Co-exposure.
Allen SA; Tran LH; Oakes HV; Brown RW; Pond BB
Neurotox Res; 2019 Jul; 36(1):132-143. PubMed ID: 30879275
[TBL] [Abstract][Full Text] [Related]
15. 3,4-Methylenedioxypyrovalerone (MDPV) and metabolites quantification in human and rat plasma by liquid chromatography-high resolution mass spectrometry.
Anizan S; Ellefsen K; Concheiro M; Suzuki M; Rice KC; Baumann MH; Huestis MA
Anal Chim Acta; 2014 May; 827():54-63. PubMed ID: 24832995
[TBL] [Abstract][Full Text] [Related]
16. Repeated exposure to 3,4-methylenedioxypyrovalerone and cocaine produces locomotor sensitization with minimal effects on brain monoamines.
Kohler RJ; Perrine SA; Baker LE
Neuropharmacology; 2018 May; 134(Pt A):22-27. PubMed ID: 29042316
[TBL] [Abstract][Full Text] [Related]
17. Synthetic cathinone MDPV enhances reward function through purinergic P2X7 receptor-dependent pathway and increases P2X7 gene expression in nucleus accumbens.
Gentile TA; Simmons SJ; Tallarida CS; Su S; Rom S; Watson MN; Reitz AB; Potula R; Rawls SM
Drug Alcohol Depend; 2019 Apr; 197():22-27. PubMed ID: 30754021
[TBL] [Abstract][Full Text] [Related]
18. 3,4-Methylenedioxypyrovalerone prevents while methylone enhances methamphetamine-induced damage to dopamine nerve endings: β-ketoamphetamine modulation of neurotoxicity by the dopamine transporter.
Anneken JH; Angoa-Pérez M; Kuhn DM
J Neurochem; 2015 Apr; 133(2):211-22. PubMed ID: 25626880
[TBL] [Abstract][Full Text] [Related]
19. 7,8-Dihydroxyflavone blocks the development of behavioral sensitization to MDPV, but not to cocaine: Differential role of the BDNF-TrkB pathway.
Duart-Castells L; López-Arnau R; Vizcaíno S; Camarasa J; Pubill D; Escubedo E
Biochem Pharmacol; 2019 May; 163():84-93. PubMed ID: 30738029
[TBL] [Abstract][Full Text] [Related]
20. Functional connectivity, behavioral and dopaminergic alterations 24 hours following acute exposure to synthetic bath salt drug methylenedioxypyrovalerone.
Colon-Perez LM; Pino JA; Saha K; Pompilus M; Kaplitz S; Choudhury N; Jagnarine DA; Geste JR; Levin BA; Wilks I; Setlow B; Bruijnzeel AW; Khoshbouei H; Torres GE; Febo M
Neuropharmacology; 2018 Jul; 137():178-193. PubMed ID: 29729891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
